Prospective phase II trial of everolimus in PIK3CA...

BMC Cancer 2017 / 12 Vol. 17; Iss. 1

Prospective phase II trial of everolimus in PIK3CA amplification/mutation and/or PTEN loss patients with advanced solid tumors refractory to standard therapy

Kim, Seung Tae, Lee, Jeeyun, Park, Se Hoon, Park, Joon Oh, Park, Young Suk, Kang, Won Ki, Lim, Ho Yeong
How much do you like this book?
What’s the quality of the file?
Download the book for quality assessment
What’s the quality of the downloaded files?
Volume:
17
Language:
english
Journal:
BMC Cancer
DOI:
10.1186/s12885-017-3196-6
Date:
December, 2017
File:
PDF, 437 KB
english, 2017
Conversion to is in progress
Conversion to is failed